𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension

✍ Scribed by Hyams, Jeffrey; Walters, Thomas D.; Crandall, Wallace; Kugathasan, Subra; Griffiths, Anne; Blank, Marion; Johanns, Jewel; Lang, Yinghua; Markowitz, James; Cohen, Stanley; Winter, Harland S.; Veereman-Wauters, Gigi; Ferry, George; Baldassano, Robert


Book ID
118276469
Publisher
Informa plc
Year
2011
Tongue
English
Weight
296 KB
Volume
27
Category
Article
ISSN
0300-7995

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of infliximab in pediatric Croh
✍ Frank M. Ruemmele; Alain Lachaux; Jean-Pierre Cézard; Alain Morali; Chantal Maur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is efficacious in inducing remission in severe forms of pediatric crohn's disease (cd). adult studies indicate that ifx is also safe and well tolerated as maintenance therapy. the present study aimed to evaluate in a prospective manner the efficacy and safety of ifx